Proton magnetic resonance spectroscopy and ultrasound for hepatic fat quantification

Hepatology Research

Volumn 40, Issue 4, 2010, Pages 399-406

  Mehta, Sanjeev R ^a   Louise Thomas, Elizabeth ^a   Patel, Nayna ^a   Crofton, Mary E ^c   McCarthy, John ^a   Eliahoo, Joseph ^b   Morin, Stanislas X ^a   Fitzpatrick, Julie ^a   Durighel, Giuliana ^a   Goldstone, Anthony P ^a   Johnston, Desmond G ^a   Bell, Jimmy D ^a   Taylor Robinson, Simon D ^a  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Intrahepatocellular lipid; Non alcoholic fatty liver disease; Proton magnetic resonance spectroscopy; Ultrasound

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGIST; SENSITIVITY AND SPECIFICITY;

EID: 77954353659     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00620.x     Document Type: Article

References (32)

1. James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998, 29:495-501.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-31.
3. Perlemuter G, Bigorgne A, Cassard-Doulcier AM. Nonalcoholic fatty liver disease: from pathogenesis to patient care. Nat Clin Pract 2007, 3:458-69.
4. Powell EE, Cooksley WG, Hanson R. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
5. Marchesini G, Brizi M, Morselli-Labate AM. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999, 107:450-5.
6. Pagano G, Pacini G, Musso G. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35:367-72.
7. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
8. Browning JD, Szczepaniak LS, Dobbins R. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-95.
9. Crowley H, Lewis WD, Gordon F. Steatosis in donor and transplant liver biopsies. Hum Pathol 2000, 31:1209-13.
10. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003, 15:539-43.
11. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clinical research ed) 1986, 292:13-15.
12. Needleman L, Kurtz AB, Rifkin MD. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 1986, 146:1011-15.
13. Joseph AE, Saverymuttu SH, Al-Sam S. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991, 43:26-31.
14. Fishbein M, Castro F, Cheruku S. Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 2005, 39:619-25.
15. Pacifico L, Celestre M, Anania C. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 2007, 96:542-7.
16. Longo R, Ricci C, Masutti F. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993, 28:297-302.
17. Longo R, Pollesello P, Ricci C. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995, 5:281-5.
18. Thomsen C, Becker U, Winkler K. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994, 12:487-95.
19. Szczepaniak LS, Babcock EE, Schick F. Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo. Am J Physiol 1999, 276:E977-89.
20. Thomas EL, Hamilton G, Patel N. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005, 54:122-7.
21. Guiu B, Petit JM, Loffroy R. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009, 250(1):95-102.
22. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997, 129(1):35-43.
23. Thomas EL, Saeed N, Hajnal JV. Magnetic resonance imaging of total body fat. J Appl Physiol 1998, 85(5):1778-85.
24. Mehta SR, Thomas EL, Bell JD. Non-invasive means of measuring hepatic fat content. World J Gastroenterol 2008, 14:3476-83.
25. Westerbacka J, Cornér A, Tiikkainen M. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004, 47(8):1360-9.
26. Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 2007, 189(6):W320-3.
27. Webb M, Yeshua H, Zelber-Sagi S. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 2009, 192(4):909-14.
28. Cowin GJ, Jonsson JR, Bauer JD. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. Magn Reson Imaging 2008, 28(4):937-45.
29. Tobari M, Hashimoto E, Yatsuji S, Torii N, Shiratori K. Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med 2009, 48(10):739-46.
30. Qayyum A, Chen DM, Breiman RS. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging 2009, 33(2):110-15.
31. Lee SW, Park SH, Kim KW. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007, 244(2):479-85.
32. Edens MA, van Ooijen PM, Post WJ. Ultrasonography to quantify hepatic fat content: validation by (1)H magnetic resonance spectroscopy: Obesity (Silver Spring). 2009, Epub ahead of print